Skip to content
PulseMS
Log inJoin
Research & community

MS research, together.

MS research in plain English. Perspectives from people who understand.

Research evidence filters

Filters apply to reviewed research. Unknown dates and unassessed posts are excluded when a corresponding filter is active.

Reset filters
Topics & sourcesFiltered
Research and community updates, newest first.#AIClear filters
AI CuratorAI-generated
Research summary ·
AI summary · not yet reviewedHuman studyNot reportedTrial registry

Observational Study on Biomarker Identification for Multiple Sclerosis

A study is planned to identify biomarkers linked to disease activity and progression in multiple sclerosis (MS) by integrating clinical, imaging, and omic data from 800 participants across four countries. Participants will provide various health data, but results are currently unavailable as enrollment has not yet started.

What this does not proveThe study is observational and does not yet demonstrate clinical outcomes. No results are available, and planned enrollment has not started.
#AI
View abstract on PubMedAI summary of a published abstract. Not medical advice.
AI CuratorAI-generated
Research summary ·
AI summary · not yet reviewedHuman studyObservationalPeer review unconfirmed

AI in Neurological Health Care: Qualitative Study of Patient and Public Perceptions

A qualitative study with 15 participants focused on perceptions of AI in managing neurological conditions such as early-onset Parkinson's, epilepsy, and multiple sclerosis found that patients perceive improved diagnostics and treatments, increased involvement in care, and resource efficiency from AI. However, concerns were raised about data preparedness and potential deskilling risks.

What this does not proveThe study does not establish the clinical efficacy of AI applications or their direct impact on patient outcomes, focusing instead on perceptions.
#AI
View abstract on PubMedPMID 42785740AI summary of a published abstract. Not medical advice.
AI CuratorAI-generated
Research summary ·
AI summary · not yet reviewedSubjects not reportedNot reportedPeer review unconfirmed

Strategies for integrating artificial intelligence and cognitive assessment to predict disability progression in relapsing-remitting multiple sclerosis

A study developed an AI model called MS-TranSurv to predict disability progression in relapsing-remitting multiple sclerosis (RRMS) using cognitive assessment data. It achieved a C-index of 0.61 and tAUROC of 0.74, indicating slightly better performance compared to traditional models, especially when using individual test-level data.

What this does not proveThe study does not establish any therapeutic efficacy or definitive patient outcomes, as the focus is strictly on prediction capabilities.
#CognitiveAssessment#AI#DisabilityProgression#RemoteMonitoringRelevant to Neurologist, DataScientist
View abstract on PubMedPMID 42789556AI summary of a published abstract. Not medical advice.